Steven Rosen, MD
Pain Management · Jenkintown, PANPI 1144294323
Payments from drug & device makers
Across 586 payments — averaging $734.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Saluda Medical Americas, Inc.$330K
- Boston Scientific$67K
- Biotronik Inc.$13K
- Flowonix Medical Incorporated$9K
- Medtronic$7K
- Spinal Simplicity, LLC$2K
- plus $4K from 19 others
Across 23 payments — averaging $1876.32 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Flowonix Medical Incorporated$33K
- Saluda Medical Americas, Inc.$11K
What the payments were for
- Consulting fees$51,08562%
- Speaking & faculty fees$11,90014%
- Travel & lodging$8,26510%
- Food & beverage$9,46312%
- Education$1,5162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Saluda Medical Americas, Inc. | 135 | $329,639 |
| Boston Scientific | 136 | $66,738 |
| Biotronik Inc. | 186 | $12,989 |
| Flowonix Medical Incorporated | 2 | $8,535 |
| Medtronic(2 entities) | 25 | $6,727 |
| Spinal Simplicity, LLC | 2 | $1,645 |
| Relievant Medsystems, Inc. | 9 | $1,239 |
| Abbott | 41 | $1,011 |
| Nevro Corp. | 15 | $347 |
| Neuroone Medical Technologies Corporation | 3 | $328 |
| Vertiflex, Inc. | 2 | $211 |
| Vertos Medical, Inc. | 2 | $132 |
| Globus Medical | 1 | $111 |
| Biotronik NRO, Inc. | 4 | $110 |
| Nalu Medical, Inc. | 2 | $102 |
| Collegium Pharmaceutical, Inc. | 4 | $92 |
| Tersera Therapeutics LLC | 1 | $91 |
| Hikma Pharmaceuticals USA | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $59 |
| Daiichi Sankyo Inc. | 4 | $55 |
| Masimo Corporation | 1 | $32 |
| Vertex | 1 | $31 |
| Valinor Pharma, LLC | 1 | $23 |
| Painteq LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Evoke SCS$46,704
- WAVEWRITER ALPHA$10,859
- Prometra II$8,535
- GENERAL PAIN MANAGEMENT$4,463
- Intracept$4,222
- HA MINUTEMAN G3-R$1,645
- WaveWriter Alpha Prime 16$842
- SPECTRA WAVEWRITER$510
- INTELLIS ADAPTIVESTIM$272
- ETERNA$221
- INTELLIS$178
- Superion ISS$134
- mild Device Kit$116
- Senza$111
- Evoke$106
How this compares
Too few pain management providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 11 | $12,987 |
| Lidocaine | 29 | $5,406 |
| Oxycodone Hcl | 296 | $5,136 |
| Tizanidine Hcl | 99 | $2,209 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 110 | $1,382 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $1,314 |
| Pregabalin | 49 | $1,177 |
| Gabapentin | 82 | $1,124 |
| Hydromorphone Hcl | 71 | $1,063 |
| Fentanyl | 18 | $997 |
| Methylprednisolone | 95 | $703 |
| Duloxetine Hcl | 37 | $697 |
| Morphine Sulfate | 29 | $667 |
| Celecoxib | 15 | $516 |
| Tramadol Hcl | 102 | $465 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er | $92 | $12,98711 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate | $63 | $66729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pain management providers in Pennsylvaniaon file to place this against a meaningful peer group, so we don't.
Other pain management in Jenkintown
- Phillip SassoAbington$50K
- Edward HeresPittsburgh$5K
- Zongfu ChenPittsburgh$4K
- Megan DillWashington$18
- Tiffany RomantinoIrwin$0
- Judith ChigerPhiladelphia$0
- Scott LoevQuakertown$0
- Simon GalapoMeadowbrook$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.